Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens Wearers

The purpose of this study is to evaluate the comparability of lens fit and lens power of a new contact lens to the lens fit and lens power of two marketed lenses.

Study Overview

• Status: Completed
• Conditions: Myopia
• Intervention / Treatment: Device: galy A Plus; Device: seno A; Device: galy A

• Study Type: Interventional
• Enrollment (Actual): 41
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United Kingdom
  • Birmingham, United Kingdom, B4 7ET
  • Surrey
    • Farnham, Surrey, United Kingdom, GU9 7EN

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 55 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Must be at least 18 years of age and no more than 55 years of age.
• Must sign written informed consent.
• Optimal spherical equivalent distance correction must be between -1.00 and -6.00 diopters.
• Have spectacle astigmatism ≤ -0.75 diopter cylinder in both eyes.
• Must have visual acuity best correctable to 20/25+3 or better for each eye.
• Must appear able and willing to adhere to the instructions set forth in this clinical protocol.
• Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: No evidence of lid abnormality or infection; No conjunctival abnormality or infection; No clinical significant slit lamp findings, (i.e., oedema, staining, scarring, vascularization, infiltrates or abnormal opacities); No other active ocular disease.
• The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of daily wear for a minimum of 1 month prior to the study) and willing to wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least five days of the week) for the duration of the study.

Exclusion Criteria:

• Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
• Any previous eye surgery involving the anterior segment.
• Pre-existing ocular disease that would preclude contact lens fitting.
• Abnormal lacrimal secretions.
• Keratoconus or other corneal irregularity.
• Pregnancy, lactating or planning a pregnancy at the time of enrollment.
• Participation in any concurrent clinical trial.
• Subject's habitual contact lens type is toric or multifocal.
• Require any concurrent ocular medication.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Double

Number of Arms

6

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: galy A Plus/ galy A / seno A; Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7
Other: galy A Plus / seno A / galy A; Pair 1: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8). Pair 3: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7
Other: galy A / galy A Plus / seno A; Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 3: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7
Other: galy A / seno A / galy A Plus; Pair 1: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 2: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8). Pair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7
Other: seno A / galy A / glay A Plus; Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8). Pair 2: galy A-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 3: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7
Other: seno A / galy A Plus / galy A; Pair 1: seno A- subjects were randomized to receive different base curves for each eye (BC: 8.4 or 8.8). Pair 2: galy A Plus-subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7). Pair 3: galy A -subjects were randomized to receive different base curves for each eye (BC: 8.3 or 8.7).	Device: galy A Plus; galyfilcon A Plus, BC: 8.3 or 8.7; Device: seno A; senofilcon A, BC:8.4 or 8.8; Device: galy A; galyfilcon A , BC: 8.3 or 8.7

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Lens Centration Acceptance	Investigator evaluated as acceptable (centered/slightly decentered) or unacceptable (substantially decentered). Number of eyes in each category will be reported by lens. This is an aggregate reporting of the lenses, combining the different base curves into a category by lens type. This is done per protocol, due to this primary outcome not being stratified by base curve.	after 15 minutes of contact lens wear
Primary Gaze Lens Movement	Investigator evaluated as acceptable (minimal or moderate movement) or unacceptable (insufficient or excessive movement). Percent of eyes in each category will be evaluated.	after 15 minutes of contact lens wear
Fit Acceptability	Investigator evaluated lens fit using a six point scale: 5-optimal...3-borderline acceptable...2-unacceptable. Percent of eyes in each category will be evaluated.	after 15 minutes of contact lens wear

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
New Lens Power Fit Match to Control Lenses	The lens power fit of test lenses will be compared to control lenses to determine if the power matches. Percent of eyes with exact power fit will be evaluated.	after 15 minutes of contact lens wear

Collaborators and Investigators

• Sponsor: Johnson & Johnson Vision Care, Inc.

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2010
• Primary Completion (Actual): November 1, 2010
• Study Completion (Actual): November 1, 2010

Study Registration Dates

• First Submitted: November 17, 2010
• First Submitted That Met QC Criteria: November 17, 2010
• First Posted (Estimate): November 19, 2010

Study Record Updates

• Last Update Posted (Actual): June 19, 2018
• Last Update Submitted That Met QC Criteria: June 18, 2018
• Last Verified: August 1, 2017

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Eye Diseases; Refractive Errors; Myopia
• Other Study ID Numbers: CR-201011